1.
Hantel A, Luskin MR, Khan I, Warner E, Patel AA, Walsh TP, DeAngelo DJ, Lathan CS, Abel GA. Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. haematol [Internet]. 2024Mar.31 [cited 2024May18];109(4):1046-52. Available from: https://haematologica.org/article/view/haematol.2023.283723